ANGIOGENESIS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2383139, encodeId=052023831394a, content=我还在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83fb10123288, createdName=ms1000001528983630, createdTime=Mon Oct 12 16:07:05 CST 2026, time=2026-10-12, status=1, ipAttribution=印度), GetPortalCommentsPageByObjectIdResponse(id=2241408, encodeId=820e22414089a, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：血管畸形 经验分享：杂志水平一般，类似Journal of neuroinflammation, 新杂志10分以下还算凑合, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Sun Dec 08 20:35:16 CST 2024, time=2024-12-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=582990, encodeId=1edf582990e8, content=如何？阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9e82187965, createdName=1208999am76(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209885, encodeId=cbf7120988516, content=投稿一周到编辑手里，编辑16天时间决定送审还是拒稿，属实有点慢。 editorial decision: reject without review on 09 apr, 2022 editor assigned on 24 mar, 2022 first submitted to angiogenesis on 18 mar, 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a00d2326358, createdName=1225ea18m09(暂无昵称), createdTime=Sat Apr 09 21:01:49 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100929, encodeId=ce211100929c1, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100930, encodeId=f049110093095, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055116, encodeId=bf501055116c7, content=2019年看它是5分，觉得可以够得上，看往年文章觉得我的绰绰有余，准备到2020年，它变成9分了，好吧，因为方向比较符合（就是做蛋白的angiogenesis调控功能，也有动物模型），所以还是有信心的（至少能送审吧）。结果模板拒稿，连送审都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:03:54 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581559, encodeId=1ee9581559e8, content=怎么样?一个多月了，有消息了吗？阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc912023178, createdName=方@@, createdTime=Sun Dec 15 00:00:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579214, encodeId=5c015e9214fe, content=有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/8d8ea466522400d2f9890cb47bbe93a8.jpg, createdBy=9b9b2171036, createdName=阳光小甜, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544196, encodeId=fac354419670, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2026-10-12 ms1000001528983630 来自印度

我还在投

2 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2383139, encodeId=052023831394a, content=我还在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83fb10123288, createdName=ms1000001528983630, createdTime=Mon Oct 12 16:07:05 CST 2026, time=2026-10-12, status=1, ipAttribution=印度), GetPortalCommentsPageByObjectIdResponse(id=2241408, encodeId=820e22414089a, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：血管畸形 经验分享：杂志水平一般，类似Journal of neuroinflammation, 新杂志10分以下还算凑合, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Sun Dec 08 20:35:16 CST 2024, time=2024-12-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=582990, encodeId=1edf582990e8, content=如何？阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9e82187965, createdName=1208999am76(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209885, encodeId=cbf7120988516, content=投稿一周到编辑手里，编辑16天时间决定送审还是拒稿，属实有点慢。 editorial decision: reject without review on 09 apr, 2022 editor assigned on 24 mar, 2022 first submitted to angiogenesis on 18 mar, 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a00d2326358, createdName=1225ea18m09(暂无昵称), createdTime=Sat Apr 09 21:01:49 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100929, encodeId=ce211100929c1, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100930, encodeId=f049110093095, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055116, encodeId=bf501055116c7, content=2019年看它是5分，觉得可以够得上，看往年文章觉得我的绰绰有余，准备到2020年，它变成9分了，好吧，因为方向比较符合（就是做蛋白的angiogenesis调控功能，也有动物模型），所以还是有信心的（至少能送审吧）。结果模板拒稿，连送审都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:03:54 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581559, encodeId=1ee9581559e8, content=怎么样?一个多月了，有消息了吗？阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc912023178, createdName=方@@, createdTime=Sun Dec 15 00:00:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579214, encodeId=5c015e9214fe, content=有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/8d8ea466522400d2f9890cb47bbe93a8.jpg, createdBy=9b9b2171036, createdName=阳光小甜, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544196, encodeId=fac354419670, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2024-12-08 1250080bm96暂无昵称来自北京

审稿速度:3.0 | 投稿命中率:95.0
偏重的研究方向：血管畸形
经验分享：杂志水平一般，类似Journal of neuroinflammation, 新杂志10分以下还算凑合

91 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2383139, encodeId=052023831394a, content=我还在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83fb10123288, createdName=ms1000001528983630, createdTime=Mon Oct 12 16:07:05 CST 2026, time=2026-10-12, status=1, ipAttribution=印度), GetPortalCommentsPageByObjectIdResponse(id=2241408, encodeId=820e22414089a, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：血管畸形 经验分享：杂志水平一般，类似Journal of neuroinflammation, 新杂志10分以下还算凑合, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Sun Dec 08 20:35:16 CST 2024, time=2024-12-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=582990, encodeId=1edf582990e8, content=如何？阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9e82187965, createdName=1208999am76(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209885, encodeId=cbf7120988516, content=投稿一周到编辑手里，编辑16天时间决定送审还是拒稿，属实有点慢。 editorial decision: reject without review on 09 apr, 2022 editor assigned on 24 mar, 2022 first submitted to angiogenesis on 18 mar, 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a00d2326358, createdName=1225ea18m09(暂无昵称), createdTime=Sat Apr 09 21:01:49 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100929, encodeId=ce211100929c1, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100930, encodeId=f049110093095, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055116, encodeId=bf501055116c7, content=2019年看它是5分，觉得可以够得上，看往年文章觉得我的绰绰有余，准备到2020年，它变成9分了，好吧，因为方向比较符合（就是做蛋白的angiogenesis调控功能，也有动物模型），所以还是有信心的（至少能送审吧）。结果模板拒稿，连送审都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:03:54 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581559, encodeId=1ee9581559e8, content=怎么样?一个多月了，有消息了吗？阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc912023178, createdName=方@@, createdTime=Sun Dec 15 00:00:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579214, encodeId=5c015e9214fe, content=有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/8d8ea466522400d2f9890cb47bbe93a8.jpg, createdBy=9b9b2171036, createdName=阳光小甜, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544196, encodeId=fac354419670, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2020-01-10 1208999am76(暂无昵称)

如何？阳光小甜 2019-11-02 发表::
有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…阳光小甜 2019-11-02 00:00:00 发表:
有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…

阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…

241 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2383139, encodeId=052023831394a, content=我还在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83fb10123288, createdName=ms1000001528983630, createdTime=Mon Oct 12 16:07:05 CST 2026, time=2026-10-12, status=1, ipAttribution=印度), GetPortalCommentsPageByObjectIdResponse(id=2241408, encodeId=820e22414089a, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：血管畸形 经验分享：杂志水平一般，类似Journal of neuroinflammation, 新杂志10分以下还算凑合, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Sun Dec 08 20:35:16 CST 2024, time=2024-12-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=582990, encodeId=1edf582990e8, content=如何？阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9e82187965, createdName=1208999am76(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209885, encodeId=cbf7120988516, content=投稿一周到编辑手里，编辑16天时间决定送审还是拒稿，属实有点慢。 editorial decision: reject without review on 09 apr, 2022 editor assigned on 24 mar, 2022 first submitted to angiogenesis on 18 mar, 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a00d2326358, createdName=1225ea18m09(暂无昵称), createdTime=Sat Apr 09 21:01:49 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100929, encodeId=ce211100929c1, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100930, encodeId=f049110093095, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055116, encodeId=bf501055116c7, content=2019年看它是5分，觉得可以够得上，看往年文章觉得我的绰绰有余，准备到2020年，它变成9分了，好吧，因为方向比较符合（就是做蛋白的angiogenesis调控功能，也有动物模型），所以还是有信心的（至少能送审吧）。结果模板拒稿，连送审都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:03:54 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581559, encodeId=1ee9581559e8, content=怎么样?一个多月了，有消息了吗？阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc912023178, createdName=方@@, createdTime=Sun Dec 15 00:00:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579214, encodeId=5c015e9214fe, content=有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/8d8ea466522400d2f9890cb47bbe93a8.jpg, createdBy=9b9b2171036, createdName=阳光小甜, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544196, encodeId=fac354419670, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2022-04-09 1225ea18m09(暂无昵称)

投稿一周到编辑手里，编辑16天时间决定送审还是拒稿，属实有点慢。
editorial decision: reject without review
on 09 apr, 2022

editor assigned
on 24 mar, 2022

first submitted to angiogenesis
on 18 mar, 2022

139 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2383139, encodeId=052023831394a, content=我还在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83fb10123288, createdName=ms1000001528983630, createdTime=Mon Oct 12 16:07:05 CST 2026, time=2026-10-12, status=1, ipAttribution=印度), GetPortalCommentsPageByObjectIdResponse(id=2241408, encodeId=820e22414089a, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：血管畸形 经验分享：杂志水平一般，类似Journal of neuroinflammation, 新杂志10分以下还算凑合, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Sun Dec 08 20:35:16 CST 2024, time=2024-12-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=582990, encodeId=1edf582990e8, content=如何？阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9e82187965, createdName=1208999am76(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209885, encodeId=cbf7120988516, content=投稿一周到编辑手里，编辑16天时间决定送审还是拒稿，属实有点慢。 editorial decision: reject without review on 09 apr, 2022 editor assigned on 24 mar, 2022 first submitted to angiogenesis on 18 mar, 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a00d2326358, createdName=1225ea18m09(暂无昵称), createdTime=Sat Apr 09 21:01:49 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100929, encodeId=ce211100929c1, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100930, encodeId=f049110093095, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055116, encodeId=bf501055116c7, content=2019年看它是5分，觉得可以够得上，看往年文章觉得我的绰绰有余，准备到2020年，它变成9分了，好吧，因为方向比较符合（就是做蛋白的angiogenesis调控功能，也有动物模型），所以还是有信心的（至少能送审吧）。结果模板拒稿，连送审都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:03:54 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581559, encodeId=1ee9581559e8, content=怎么样?一个多月了，有消息了吗？阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc912023178, createdName=方@@, createdTime=Sun Dec 15 00:00:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579214, encodeId=5c015e9214fe, content=有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/8d8ea466522400d2f9890cb47bbe93a8.jpg, createdBy=9b9b2171036, createdName=阳光小甜, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544196, encodeId=fac354419670, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

每个期刊梯度一般情况下选择几个备选期刊合适？

143 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2383139, encodeId=052023831394a, content=我还在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83fb10123288, createdName=ms1000001528983630, createdTime=Mon Oct 12 16:07:05 CST 2026, time=2026-10-12, status=1, ipAttribution=印度), GetPortalCommentsPageByObjectIdResponse(id=2241408, encodeId=820e22414089a, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：血管畸形 经验分享：杂志水平一般，类似Journal of neuroinflammation, 新杂志10分以下还算凑合, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Sun Dec 08 20:35:16 CST 2024, time=2024-12-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=582990, encodeId=1edf582990e8, content=如何？阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9e82187965, createdName=1208999am76(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209885, encodeId=cbf7120988516, content=投稿一周到编辑手里，编辑16天时间决定送审还是拒稿，属实有点慢。 editorial decision: reject without review on 09 apr, 2022 editor assigned on 24 mar, 2022 first submitted to angiogenesis on 18 mar, 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a00d2326358, createdName=1225ea18m09(暂无昵称), createdTime=Sat Apr 09 21:01:49 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100929, encodeId=ce211100929c1, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100930, encodeId=f049110093095, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055116, encodeId=bf501055116c7, content=2019年看它是5分，觉得可以够得上，看往年文章觉得我的绰绰有余，准备到2020年，它变成9分了，好吧，因为方向比较符合（就是做蛋白的angiogenesis调控功能，也有动物模型），所以还是有信心的（至少能送审吧）。结果模板拒稿，连送审都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:03:54 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581559, encodeId=1ee9581559e8, content=怎么样?一个多月了，有消息了吗？阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc912023178, createdName=方@@, createdTime=Sun Dec 15 00:00:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579214, encodeId=5c015e9214fe, content=有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/8d8ea466522400d2f9890cb47bbe93a8.jpg, createdBy=9b9b2171036, createdName=阳光小甜, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544196, encodeId=fac354419670, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2021-12-27 衣谷

我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？

153 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2383139, encodeId=052023831394a, content=我还在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83fb10123288, createdName=ms1000001528983630, createdTime=Mon Oct 12 16:07:05 CST 2026, time=2026-10-12, status=1, ipAttribution=印度), GetPortalCommentsPageByObjectIdResponse(id=2241408, encodeId=820e22414089a, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：血管畸形 经验分享：杂志水平一般，类似Journal of neuroinflammation, 新杂志10分以下还算凑合, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Sun Dec 08 20:35:16 CST 2024, time=2024-12-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=582990, encodeId=1edf582990e8, content=如何？阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9e82187965, createdName=1208999am76(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209885, encodeId=cbf7120988516, content=投稿一周到编辑手里，编辑16天时间决定送审还是拒稿，属实有点慢。 editorial decision: reject without review on 09 apr, 2022 editor assigned on 24 mar, 2022 first submitted to angiogenesis on 18 mar, 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a00d2326358, createdName=1225ea18m09(暂无昵称), createdTime=Sat Apr 09 21:01:49 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100929, encodeId=ce211100929c1, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100930, encodeId=f049110093095, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055116, encodeId=bf501055116c7, content=2019年看它是5分，觉得可以够得上，看往年文章觉得我的绰绰有余，准备到2020年，它变成9分了，好吧，因为方向比较符合（就是做蛋白的angiogenesis调控功能，也有动物模型），所以还是有信心的（至少能送审吧）。结果模板拒稿，连送审都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:03:54 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581559, encodeId=1ee9581559e8, content=怎么样?一个多月了，有消息了吗？阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc912023178, createdName=方@@, createdTime=Sun Dec 15 00:00:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579214, encodeId=5c015e9214fe, content=有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/8d8ea466522400d2f9890cb47bbe93a8.jpg, createdBy=9b9b2171036, createdName=阳光小甜, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544196, encodeId=fac354419670, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2021-09-26 ms3000001738384174

2019年看它是5分，觉得可以够得上，看往年文章觉得我的绰绰有余，准备到2020年，它变成9分了，好吧，因为方向比较符合（就是做蛋白的angiogenesis调控功能，也有动物模型），所以还是有信心的（至少能送审吧）。结果模板拒稿，连送审都没有！

149 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2383139, encodeId=052023831394a, content=我还在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83fb10123288, createdName=ms1000001528983630, createdTime=Mon Oct 12 16:07:05 CST 2026, time=2026-10-12, status=1, ipAttribution=印度), GetPortalCommentsPageByObjectIdResponse(id=2241408, encodeId=820e22414089a, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：血管畸形 经验分享：杂志水平一般，类似Journal of neuroinflammation, 新杂志10分以下还算凑合, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Sun Dec 08 20:35:16 CST 2024, time=2024-12-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=582990, encodeId=1edf582990e8, content=如何？阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9e82187965, createdName=1208999am76(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209885, encodeId=cbf7120988516, content=投稿一周到编辑手里，编辑16天时间决定送审还是拒稿，属实有点慢。 editorial decision: reject without review on 09 apr, 2022 editor assigned on 24 mar, 2022 first submitted to angiogenesis on 18 mar, 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a00d2326358, createdName=1225ea18m09(暂无昵称), createdTime=Sat Apr 09 21:01:49 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100929, encodeId=ce211100929c1, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100930, encodeId=f049110093095, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055116, encodeId=bf501055116c7, content=2019年看它是5分，觉得可以够得上，看往年文章觉得我的绰绰有余，准备到2020年，它变成9分了，好吧，因为方向比较符合（就是做蛋白的angiogenesis调控功能，也有动物模型），所以还是有信心的（至少能送审吧）。结果模板拒稿，连送审都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:03:54 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581559, encodeId=1ee9581559e8, content=怎么样?一个多月了，有消息了吗？阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc912023178, createdName=方@@, createdTime=Sun Dec 15 00:00:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579214, encodeId=5c015e9214fe, content=有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/8d8ea466522400d2f9890cb47bbe93a8.jpg, createdBy=9b9b2171036, createdName=阳光小甜, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544196, encodeId=fac354419670, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2019-12-15 方@@

怎么样?一个多月了，有消息了吗？阳光小甜 2019-11-02 00:00:00 发表:
有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…

阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…

243 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2383139, encodeId=052023831394a, content=我还在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83fb10123288, createdName=ms1000001528983630, createdTime=Mon Oct 12 16:07:05 CST 2026, time=2026-10-12, status=1, ipAttribution=印度), GetPortalCommentsPageByObjectIdResponse(id=2241408, encodeId=820e22414089a, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：血管畸形 经验分享：杂志水平一般，类似Journal of neuroinflammation, 新杂志10分以下还算凑合, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Sun Dec 08 20:35:16 CST 2024, time=2024-12-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=582990, encodeId=1edf582990e8, content=如何？阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9e82187965, createdName=1208999am76(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209885, encodeId=cbf7120988516, content=投稿一周到编辑手里，编辑16天时间决定送审还是拒稿，属实有点慢。 editorial decision: reject without review on 09 apr, 2022 editor assigned on 24 mar, 2022 first submitted to angiogenesis on 18 mar, 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a00d2326358, createdName=1225ea18m09(暂无昵称), createdTime=Sat Apr 09 21:01:49 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100929, encodeId=ce211100929c1, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100930, encodeId=f049110093095, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055116, encodeId=bf501055116c7, content=2019年看它是5分，觉得可以够得上，看往年文章觉得我的绰绰有余，准备到2020年，它变成9分了，好吧，因为方向比较符合（就是做蛋白的angiogenesis调控功能，也有动物模型），所以还是有信心的（至少能送审吧）。结果模板拒稿，连送审都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:03:54 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581559, encodeId=1ee9581559e8, content=怎么样?一个多月了，有消息了吗？阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc912023178, createdName=方@@, createdTime=Sun Dec 15 00:00:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579214, encodeId=5c015e9214fe, content=有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/8d8ea466522400d2f9890cb47bbe93a8.jpg, createdBy=9b9b2171036, createdName=阳光小甜, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544196, encodeId=fac354419670, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2019-11-02 阳光小甜

有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…

276 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2383139, encodeId=052023831394a, content=我还在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=83fb10123288, createdName=ms1000001528983630, createdTime=Mon Oct 12 16:07:05 CST 2026, time=2026-10-12, status=1, ipAttribution=印度), GetPortalCommentsPageByObjectIdResponse(id=2241408, encodeId=820e22414089a, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：血管畸形 经验分享：杂志水平一般，类似Journal of neuroinflammation, 新杂志10分以下还算凑合, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=83912531155, createdName=1250080bm96暂无昵称, createdTime=Sun Dec 08 20:35:16 CST 2024, time=2024-12-08, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=582990, encodeId=1edf582990e8, content=如何？阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 发表:: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c9e82187965, createdName=1208999am76(暂无昵称), createdTime=Fri Jan 10 00:00:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209885, encodeId=cbf7120988516, content=投稿一周到编辑手里，编辑16天时间决定送审还是拒稿，属实有点慢。 editorial decision: reject without review on 09 apr, 2022 editor assigned on 24 mar, 2022 first submitted to angiogenesis on 18 mar, 2022, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a00d2326358, createdName=1225ea18m09(暂无昵称), createdTime=Sat Apr 09 21:01:49 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100929, encodeId=ce211100929c1, content=每个期刊梯度一般情况下选择几个备选期刊合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100930, encodeId=f049110093095, content=我能直接投nature/science这种顶级杂志吗？它们会反馈意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055116, encodeId=bf501055116c7, content=2019年看它是5分，觉得可以够得上，看往年文章觉得我的绰绰有余，准备到2020年，它变成9分了，好吧，因为方向比较符合（就是做蛋白的angiogenesis调控功能，也有动物模型），所以还是有信心的（至少能送审吧）。结果模板拒稿，连送审都没有！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23305505580, createdName=ms3000001738384174, createdTime=Sun Sep 26 21:03:54 CST 2021, time=2021-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581559, encodeId=1ee9581559e8, content=怎么样?一个多月了，有消息了吗？阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=阳光小甜 2019-11-02 00:00:00 发表: 有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc912023178, createdName=方@@, createdTime=Sun Dec 15 00:00:00 CST 2019, time=2019-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579214, encodeId=5c015e9214fe, content=有人投过这个杂志吗？我的在编辑手上一周了，怎么还没给我送审？要拒就快点啊…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/03/19/8d8ea466522400d2f9890cb47bbe93a8.jpg, createdBy=9b9b2171036, createdName=阳光小甜, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544196, encodeId=fac354419670, content=过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=413, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yangbin2015, createdTime=Sun Jul 16 19:02:00 CST 2017, time=2017-07-16, status=1, ipAttribution=)]

2017-07-16 yangbin2015

过5分大关,可喜可贺,明年再上一层楼,过6分大关,那就更不一样了.

413 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务